We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Dam, the consequences Updated  An academic journal has retracted two papers because it determined their authors used unlicensed software.… As noted by Retraction Watch, Elsevier's Ain Shams ...

The fact that our faculty are among the most cited of people across their disciplines says that the contributions that we're ...

Monogenic forms of early onset severe childhood obesity (ie, presenting before the age of 5 years) can occur in the context ...

This internship offers hands-on experience with cutting-edge AI technology and access to Elsevier's extensive computational resources and databases.

The Budget brought good news for those of us with Stocks and Shares ISAs! I’ve been looking at this one stock to add to mine.

Elsevier, a global leader in information and analytics, and provider of data and AI-enabled decision support tools for innovation in life sciences, today announced a commitment to support global ...

J.P. Morgan analyst Daniel Kerven maintained a Buy rating on RELX plc (RLXXF – Research Report) today and set a price target of £45.50.